

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Ibritumomab yindlela ekhethekile yokwelapha umdlavuza ehlanganisa ukwelashwa okuqondiwe nemithi enomoya-mpilo ukuze kulwiwe nezinhlobo ezithile zomdlavuza wegazi. Le mithi isebenza njengemishini eqondisiwe, ifuna futhi inamathele kumaseli athile omdlavuza emzimbeni wakho ngaphambi kokuletha imisebe ngqo ukuze iwabhubhise. Isetshenziswa ikakhulukazi ekwelapheni i-non-Hodgkin's lymphoma, uhlobo lomdlavuza wegazi oluthinta isimiso sakho se-lymphatic.
I-Ibritumomab iyidrayisi ye-radioimmunotherapy ehlanganisa i-antibody nento enomoya-mpilo. Cabanga ngayo njengokwelashwa okunezinhlangothi ezimbili lapho i-antibody isebenza njengesistimu ye-GPS, ithola amaseli omdlavuza, kuyilapho ingxenye enomoya-mpilo iletha imisebe eqondiwe ukuze iwabhubhise. Igama eliphelele ongase ulibone lithi ibritumomab tiuxetan, futhi linikezwa ngomugqa we-IV ungene egazini lakho.
Le mithi ingeyodwa yeqembu elibizwa ngokuthi ama-monoclonal antibodies, okuyizinhlobo zamaprotheni akhelwe ngokukhethekile angakwazi ukuqaphela futhi abophe ezintweni ezithile kumaseli omdlavuza. Okwenza i-ibritumomab ihluke ukuthi “inerejiyo-labeled,” okusho ukuthi ithwele impahla enomoya-mpilo engabulala amaseli omdlavuza ngaphakathi uma isinamathele kuwo.
I-Ibritumomab ivunyelwe ngokuqondile ukwelapha izinhlobo ezithile ze-non-Hodgkin's lymphoma, ikakhulukazi i-follicular lymphoma kanye nezinye i-B-cell lymphomas. Udokotela wakho angase ancome lokhu kwelashwa uma une-lymphoma ebuyele ngemva kokwelashwa okuhlukile noma engazange isabele kahle ekhemotherapy ejwayelekile.
Le mithi ivame ukucatshangelwa uma amaseli akho omdlavuza eneprotheni ethile ebizwa ngokuthi i-CD20 ebusweni bawo. Ithimba lakho lezempilo lizohlola amaseli akho omdlavuza ukuze liqinisekise ukuthi anale nhloso ngaphambi kokuncoma i-ibritumomab. Ivame ukusetshenziswa njengengxenye yohlelo lokwelapha olungase luhlanganise neminye imithi ukusiza ukulungisa umzimba wakho futhi kuthuthukise ukusebenza kahle kokwelashwa.
I-Ibritumomab isebenza ngokuletha imisebe eqondiswe ngqo emangqamuzaneni omdlavuza ngenkathi inciphisa umonakalo emangqamuzaneni anempilo. Ingxenye yama-antibody ifuna amaprotheni e-CD20 atholakala ebusweni bamaseli athile e-lymphoma. Lapho isewatholile futhi inamathisela kula maseli, ingxenye enomoya oyingozi iletha imisebe egxilile ebulala amangqamuzana omdlavuza ngaphakathi.
Lokhu kuthathwa njengokwelashwa komdlavuza okuphakathi nendawo okuqondiswe kakhulu kune-chemotherapy yendabuko. Imisebe eyilethayo inobubanzi obufushane, okusho ukuthi ithinta ikakhulukazi amangqamuzana omdlavuza enamathele kuwo kunokuthi isakazeke emzimbeni wakho wonke. Le ndlela eqondisiwe ingasiza ekunciphiseni eminye yemiphumela emibi ongase uyithole ngemithi yomsebe ebanzi.
I-Ibritumomab inikezwa kuphela esibhedlela noma esikhungweni esikhethekile sokwelashwa komdlavuza ngabasebenzi bezempilo abaqeqeshiwe. Uzoyithola ngomugqa we-IV, okusho ukuthi ingena ngqo emjondolo wakho wegazi ngenaliti engalweni yakho noma ngomugqa ophakathi uma unawo.
Ukwelashwa kuvame ukubandakanya ukufakwa okubili okuhlukene okunikezwa cishe ngesonto elilodwa. Ngaphambi kokufakwa ngakunye, ngokuvamile uzothola eminye imithi ukusiza ukulungisa umzimba wakho futhi kunciphise ubungozi bokungezwani komzimba. Akudingeki ukuthi udle noma ugweme ukudla ngaphambi kokwelashwa, kodwa ithimba lakho lezempilo lizokunikeza imiyalelo ethile ngokusekelwe esimweni sakho.
Ngesikhathi sokufakwa, uzoqashwa eduze nganoma yiziphi izindlela. Inqubo yokufakwa ingathatha amahora amaningana, ngakho-ke ungase ufune ukuletha okuthile ukuze uzigcine ukhululekile, njengencwadi noma umculo. Ngemva kokwelashwa, uzodinga ukulandela izinyathelo zokuphepha ezikhethekile ngoba uzoba nezinto ezinomoya oyingozi emzimbeni wakho izinsuku ezimbalwa.
Ibritumomab ngokuvamile inikezwa njengendlela eyodwa yokwelashwa kunokuba kube imithi eqhubekayo. Abantu abaningi bathola ukumnika okubili okungaba yizinsuku eziyisikhombisa kuya kweziyisishiyagalolunye ngaphandle, futhi lokho kuqeda umjikelezo wokwelashwa. Ngokungafani nemithi yansuku zonke, lokhu kuvame ukuba ukwelashwa okukodwa.
Udokotela wakho uzoqapha impendulo yakho ekwelashweni emasontweni nasezinyangeni ezilandelayo ngokusebenzisa ukuhlolwa kwegazi kanye nezifundo zokucabanga. Ngokuya ngokuthi umdlavuza wakho uphendula kanjani nempilo yakho yonke, ithimba lakho lezempilo lingase lincomende ukwelashwa okwengeziwe, kodwa i-ibritumomab ngokwayo ngokuvamile ayiphindwa ngokushesha ngenxa yemiphumela yayo emnkantshweni wakho wamathambo.
Njengazo zonke izindlela zokwelapha umdlavuza, i-ibritumomab ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyithola ngendlela efanayo. Imiphumela emibi evame kakhulu ihlobene nemiphumela yayo emangqamuzaneni akho egazi kanye nesistimu yokuzivikela komzimba.
Nansi imiphumela emibi ongase uyithole, ukhumbula ukuthi ithimba lakho lezempilo lizokuqapha ngokucophelela futhi lisize ekuphatheni noma yiziphi izimpawu eziphakamayo:
Abanye abantu bangase babe nemiphumela emibi ebucayi kodwa engavamile. Lokhu okungenzeka okungavamile kufaka phakathi ukwehla okukhulu ekubalweni kwamangqamuzana egazi okungase kube yingozi empilweni, izifo ezinzima, noma imidlavuza yesibili engase ivele ezinyangeni noma eminyakeni emva kwalokho. Ithimba lakho lezempilo lizoxoxa ngalezi zingozi nawe futhi likuqaphe ngokucophelela ngesikhathi nangemva kokwelashwa.
Ibritumomab akufaneleki kuwo wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi kufanele yini kuwe. Akufanele uthole lokhu kwelashwa uma ukhulelwe noma uncelisa, ngoba imisebe ingalimaza ingane esakhula.
Udokotela wakho uzophinda aqaphele ngokuncoma i-ibritumomab uma unezimo ezithile zempilo. Lezi zimo zidinga ukucatshangelwa okukhethekile futhi zingenza lokhu kwelashwa kungafaneleki kuwe:
Ithimba lakho lezempilo lizokwenza izivivinyo eziphelele ngaphambi kokwelashwa ukuze liqinisekise ukuthi umzimba wakho ungakwazi ukubhekana nalokhu kwelashwa ngokuphepha. Bazophinda bacabangele impilo yakho yonke, ukwelashwa kwangaphambilini, kanye nemithi yamanje ukuze banqume ukuthi i-ibritumomab iyona ndlela engcono kakhulu yesimo sakho esithile.
I-Ibritumomab ithengiswa ngaphansi kwegama lomkhiqizo elithi Zevalin. Uma ubona leli gama ohlelweni lwakho lokwelashwa noma emaphepheni omshwalense, libhekisela emuthini ofanayo. Abanye abahlinzeki bezempilo bangase basebenzise noma yiliphi igama lapho bexoxa ngokwelashwa kwakho, ngakho-ke ungadideki uma uzwa womabili la magama.
I-Zevalin yenziwa yizinkampani ezithile zemithi futhi itholakala kuphela ngezikhungo zokwelashwa komdlavuza ezikhethekile. Ithimba lakho lezempilo lizoxhumana nabahlinzeki abafanele ukuqinisekisa ukuthi uthola umuthi uma uwudinga.
Uma i-ibritumomab ingafaneleki kuwe, ezinye izinketho zokwelapha zingase zitholakale ohlotsheni lwakho lwe-lymphoma. Udokotela wakho angase ancome ezinye izidakamizwa ze-monoclonal ezifana ne-rituximab, eziqondiswe kuphrotheni efanayo ye-CD20 kodwa ezingathwali impahla enomsakazo.
Ezinye izindlela ezingase zihlanganise izinhlobo ezahlukene zokwelashwa okuhloswe ngakho, inhlanganisela yamakhemikhali yendabuko, noma ukwelashwa okusha njenge-CAR-T cell therapy, kuye ngesimo sakho esithile. Udokotela wakho we-oncologist uzosebenza nawe ukuthola ukwelashwa okufanele kakhulu ngokusekelwe ohlotsheni lwakho lomdlavuza, impilo yonke, nomlando wokwelashwa.
Kokubili i-ibritumomab ne-rituximab zihlose iphrotheni efanayo ye-CD20 kumaseli e-lymphoma, kodwa zisebenza ngendlela ehlukile. I-Rituximab iyi-antibody “enqunu” engathwali impahla enomsakazo, kuyilapho i-ibritumomab ihlanganisa i-antibody nemisebe eqondiwe.
Izifundo zikhombisile ukuthi i-ibritumomab ingasebenza ngempumelelo kune-rituximab yodwa ezimweni ezithile, ikakhulukazi i-follicular lymphoma ebuyele ngemva kokunye ukwelashwa. Nokho, i-ibritumomab iphinde ithwale izingozi ezengeziwe ngenxa yengxenye enomsakazo, okuhlanganisa imiphumela emibi kakhulu ekubalweni kwamaseli egazi kanye nezinkinga ezingase zibe khona zesikhathi eside.
Ukukhetha phakathi kwale mithi kuncike ezintweni eziningi ezihlanganisa uhlobo lwakho oluthile lwe-lymphoma, ukwelashwa kwangaphambilini, impilo yonke, nezintandokazi zomuntu siqu. Ithimba lakho lokunakekelwa kwezempilo lizokusiza ukuthi ulinganise izinzuzo ezingaba khona kanye nezingozi zenketho ngayinye ukuze wenze isinqumo esingcono kakhulu sesimo sakho.
I-Ibritumomab ingasetshenziswa kubantu abanezifo zenhliziyo, kodwa idinga ukuhlolwa nokuqapha okucophelelayo. Udokotela wakho we-cardiologist kanye ne-oncologist bazosebenza ndawonye ukuhlola ukuthi isimo sakho senhliziyo sizinzile yini ngokwanele ukuze sibhekane nokwelashwa nemiphumela yaso engaba khona.
Okukhathaza kakhulu ukuthi i-ibritumomab ingabangela ukubalwa kwamangqamuzana egazi okuphansi, okungase kubeke ingcindezi eyengeziwe enhliziyweni yakho. Ithimba lakho lokunakekelwa kwezempilo lizokuqapha eduze ngesikhathi sokwelashwa futhi lingase lilungise uhlelo lwakho lokunakekela ngokusekelwe endleleni inhliziyo yakho esabela ngayo.
Njengoba i-ibritumomab inikezwa kuphela ochwepheshe bezempilo abaqeqeshiwe ezikhungweni zezokwelapha, ukweqisa ngengozi akuvamile kakhulu. Umuthi ubalwa ngokucophelela ngokusekelwe esisindweni somzimba wakho futhi unikezwa ngaphansi kokuqashwa kwezokwelapha okuqinile.
Uma ukhathazekile ngomthamo wakho noma uhlangabezana nezimpawu ezingavamile ngemva kokwelashwa, xhumana nethimba lakho lezempilo ngokushesha. Bangahlola isimo sakho futhi banikeze ukunakekelwa okufanele uma kudingeka. Isikhungo sezokwelapha lapho uthola khona ukwelashwa sizoba nezimiso zokubhekana nanoma yiziphi izinkinga ezingase zivele.
Uma uphuthelwa ukufakwa kwakho kwe-ibritumomab okuhleliwe, xhumana nethimba lakho lezempilo ngokushesha ukuze lihlehlise. Ngenxa yokuthi lokhu kwelashwa kuhilela izinto ezinomsakazo futhi kulandela isimiso sesikhathi esithile, kubalulekile ukuxhumana nethimba lakho lezokwelapha kunokuzama ukulungisa isimiso ngokwakho.
Ithimba lakho lezempilo lizinquma indlela engcono kakhulu yokuqhubeka ngayo ngokusekelwe ekutheni isikhathi esingakanani esidlulile kanye nohlelo lwakho lokwelashwa olujwayelekile. Kungase kudingeke ukuthi baqale kabusha imithi ethile yokulungiselela noma balungise isikhathi somjikelezo wakho wokwelashwa.
I-Ibritumomab ngokuvamile inikezwa njengenkambo yokwelashwa ephelele kunokuba ibe umuthi oqhubekayo. Abantu abaningi bathola ukufakwa okubili ngesonto elilodwa, futhi lokho kuqeda ukwelashwa. Awuvamile ukuyeka ukuthatha i-ibritumomab ngendlela efanayo ongayeka ngayo umuthi wansuku zonke.
Ngemva kokuthi inkambo yakho yokwelashwa isiqediwe, ithimba lakho lezempilo lizobheka impendulo yakho ngokuhlolwa okuvamile, ukuhlolwa kwegazi, kanye nezifundo zokucabanga. Bazokwazisa uma kudingeka ukwelashwa okwengeziwe ngokusekelwe ekutheni umdlavuza wakho uphendula kanjani.
Izinto ezinomsakazo ku-ibritumomab zinesikhathi esifushane sokuphila, okusho ukuthi zilahlekelwa umsakazo ngokushesha. Iningi le-radioactivity lizobe selinyamale emzimbeni wakho kungakapheli amasonto amabili ngemuva kokwelashwa, ngamazinga aphezulu kakhulu ekhona ezinsukwini ezimbalwa zokuqala.
Ngesikhathi esinjalo, kuzodingeka ukuthi ulandele izinyathelo zokuphepha ezikhethekile ukuvikela abanye ekuchayekeni emisebeni. Ithimba lakho lezempilo lizokunikeza imiyalelo enemininingwane mayelana nokuhlala ebangeni eliphephile kwabanye, ikakhulukazi abesifazane abakhulelwe kanye nezingane ezincane, nokulahla kahle uketshezi lomzimba. Lezi zinyathelo zokuphepha zesikhashana futhi zizosulwa uma i-radioactivity isehle yaba ngamazinga aphephile.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.